Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kangshengbao Biotechnology is a Chinese medical technology company specializing in the development and manufacturing of pathological and molecular diagnostic products. As a core subsidiary of the Kindstar Global group, the company offers a comprehensive portfolio of reagents and equipment for immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and molecular pathology. Their offerings include a wide range of high-affinity primary antibodies, detection kits, and automated staining systems designed to standardize and enhance the accuracy of cancer diagnostics. The company serves as an integrated solution provider for pathology departments across China, supporting precision medicine through advanced screening and diagnostic tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kangshengbao Biotechnology.